COMP <GO>
WAT vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Waters Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: WAT 5
— MRK 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $462.72 (-3.61%) • MKT CAP: $47.17B
options-implied-move
7.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WAT VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WAT | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.30% | 74.80% | -15.50 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | 20.70% | -3.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 51.5x | 15.3x | +36.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 1.08% | 3.42% | -2.34 | MRK | /fcf-yield <GO> |
| Operating Margin | 25.40% | 34.30% | -8.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 20.30% | 28.10% | -7.80 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 1.30% | +5.70 | WAT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.49 | 5.19 | +10.30 | WAT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | WAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.00% | 6.60% | +0.40 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.9 | 56.9 | +3.02 | WAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.92 | +0.10 | WAT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 68.3x | 18.4x | +49.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $47.17B | $361.02B | -$313.86B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WAT REV | MRK REV | WAT GROSS % | MRK GROSS % | WAT FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.17B | $65.01B | 59.3% | 74.8% | $510.1M | $12.36B |
| FY 2024 | $2.96B | $64.17B | 59.4% | 76.3% | $629.0M | $18.10B |
| FY 2023 | $2.96B | $60.12B | 44.0% | 44.0% | $469.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WAT // BETA 1.02
MRK // BETA 0.92